These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 16825198)
21. Influence of soluble or matrix-bound isoforms of vascular endothelial growth factor-A on tumor response to vascular-targeted strategies. Akerman S; Fisher M; Daniel RA; Lefley D; Reyes-Aldasoro CC; Lunt SJ; Harris S; Bjorndahl M; Williams LJ; Evans H; Barber PR; Prise VE; Vojnovic B; Kanthou C; Tozer GM Int J Cancer; 2013 Dec; 133(11):2563-76. PubMed ID: 23712501 [TBL] [Abstract][Full Text] [Related]
22. Neuropeptide Y Y5-receptor activation on breast cancer cells acts as a paracrine system that stimulates VEGF expression and secretion to promote angiogenesis. Medeiros PJ; Jackson DN Peptides; 2013 Oct; 48():106-13. PubMed ID: 23932937 [TBL] [Abstract][Full Text] [Related]
23. The PPARβ agonist L-165041 promotes VEGF mRNA stabilization in HPV18-harboring HeLa cells through a receptor-independent mechanism. Roche E; Lascombe I; Bittard H; Mougin C; Fauconnet S Cell Signal; 2014 Feb; 26(2):433-43. PubMed ID: 24172859 [TBL] [Abstract][Full Text] [Related]
24. Bone marrow-derived, alternatively activated macrophages enhance solid tumor growth and lung metastasis of mammary carcinoma cells in a Balb/C mouse orthotopic model. Cho HJ; Jung JI; Lim DY; Kwon GT; Her S; Park JH; Park JH Breast Cancer Res; 2012 May; 14(3):R81. PubMed ID: 22616919 [TBL] [Abstract][Full Text] [Related]
25. Identification of colorectal cancer metastasis markers by an angiogenesis-related cytokine-antibody array. Abajo A; Bitarte N; Zarate R; Boni V; Lopez I; Gonzalez-Huarriz M; Rodriguez J; Bandres E; Garcia-Foncillas J World J Gastroenterol; 2012 Feb; 18(7):637-45. PubMed ID: 22363134 [TBL] [Abstract][Full Text] [Related]
26. p21-activated kinase-1 signaling mediates cyclin D1 expression in mammary epithelial and cancer cells. Balasenthil S; Sahin AA; Barnes CJ; Wang RA; Pestell RG; Vadlamudi RK; Kumar R J Biol Chem; 2004 Jan; 279(2):1422-8. PubMed ID: 14530270 [TBL] [Abstract][Full Text] [Related]
27. VEGFR-2 expression in malignant tumours of the canine mammary gland: a prospective survival study. Santos A; Lopes C; Gärtner F; Matos AJ Vet Comp Oncol; 2016 Sep; 14(3):e83-92. PubMed ID: 24976305 [TBL] [Abstract][Full Text] [Related]
28. Expression of angiogenic regulators, VEGF and leptin, is regulated by the EGF/PI3K/STAT3 pathway in colorectal cancer cells. Cascio S; Ferla R; D'Andrea A; Gerbino A; Bazan V; Surmacz E; Russo A J Cell Physiol; 2009 Oct; 221(1):189-94. PubMed ID: 19492417 [TBL] [Abstract][Full Text] [Related]
29. Role of adipokines and cytokines in obesity-associated breast cancer: therapeutic targets. Khan S; Shukla S; Sinha S; Meeran SM Cytokine Growth Factor Rev; 2013 Dec; 24(6):503-13. PubMed ID: 24210902 [TBL] [Abstract][Full Text] [Related]
30. Autocrine and paracrine roles of VEGF/VEGFR-2 and VEGF-C/VEGFR-3 signaling in angiosarcomas of the scalp and face. Tokuyama W; Mikami T; Masuzawa M; Okayasu I Hum Pathol; 2010 Mar; 41(3):407-14. PubMed ID: 19913279 [TBL] [Abstract][Full Text] [Related]
31. An autocrine VEGF/VEGFR2 and p38 signaling loop confers resistance to 4-hydroxytamoxifen in MCF-7 breast cancer cells. Aesoy R; Sanchez BC; Norum JH; Lewensohn R; Viktorsson K; Linderholm B Mol Cancer Res; 2008 Oct; 6(10):1630-8. PubMed ID: 18922978 [TBL] [Abstract][Full Text] [Related]
32. VEGF-A/VEGFR-2 signaling plays an important role for the motility of pancreas cancer cells. Doi Y; Yashiro M; Yamada N; Amano R; Noda S; Hirakawa K Ann Surg Oncol; 2012 Aug; 19(8):2733-43. PubMed ID: 22207048 [TBL] [Abstract][Full Text] [Related]
33. The effect of bevacizumab on human malignant melanoma cells with functional VEGF/VEGFR2 autocrine and intracrine signaling loops. Adamcic U; Skowronski K; Peters C; Morrison J; Coomber BL Neoplasia; 2012 Jul; 14(7):612-23. PubMed ID: 22904678 [TBL] [Abstract][Full Text] [Related]
34. Regulation of constitutive vascular endothelial growth factor secretion in retinal pigment epithelium/choroid organ cultures: p38, nuclear factor κB, and the vascular endothelial growth factor receptor-2/phosphatidylinositol 3 kinase pathway. Klettner A; Westhues D; Lassen J; Bartsch S; Roider J Mol Vis; 2013; 19():281-91. PubMed ID: 23401656 [TBL] [Abstract][Full Text] [Related]
35. Vascular endothelial growth factor as an autocrine survival factor for retinal pigment epithelial cells under oxidative stress via the VEGF-R2/PI3K/Akt. Byeon SH; Lee SC; Choi SH; Lee HK; Lee JH; Chu YK; Kwon OW Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1190-7. PubMed ID: 19834034 [TBL] [Abstract][Full Text] [Related]
36. Leptin regulation of proangiogenic molecules in benign and cancerous endometrial cells. Carino C; Olawaiye AB; Cherfils S; Serikawa T; Lynch MP; Rueda BR; Gonzalez RR Int J Cancer; 2008 Dec; 123(12):2782-90. PubMed ID: 18798554 [TBL] [Abstract][Full Text] [Related]
37. Overproduction of VEGF concomitantly expressed with its receptors promotes growth and survival of melanoma cells through MAPK and PI3K signaling. Graells J; Vinyals A; Figueras A; Llorens A; Moreno A; Marcoval J; Gonzalez FJ; Fabra A J Invest Dermatol; 2004 Dec; 123(6):1151-61. PubMed ID: 15610528 [TBL] [Abstract][Full Text] [Related]
38. Astrocyte growth effects of vascular endothelial growth factor (VEGF) application to perinatal neocortical explants: receptor mediation and signal transduction pathways. Mani N; Khaibullina A; Krum JM; Rosenstein JM Exp Neurol; 2005 Apr; 192(2):394-406. PubMed ID: 15755557 [TBL] [Abstract][Full Text] [Related]
40. [Inhibition of bladder cancer cell growth and angiogenesis by co-blockage of vascular endothelial growth factor and its receptor KDR]. Chen XL; Liu LC; Xu ZG; Li Z; Li RW; Gao RJ; Wang S; Zhang M; Guo H Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):578-82. PubMed ID: 19102933 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]